Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Polycystic ovary syndrome, a disorder causing menstrual issues and infertility, can be treated with lifestyle changes, medication, herbal remedies, surgery, and assisted reproductive techniques like artificial insemination and IVF.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The document describes a way to measure biotin in blood to prevent wrong test results in hormone level testing.

Congenital Adrenal Hyperplasia is a rare inherited disease causing hormone imbalances, affecting growth, fertility, and heart health, diagnosed through blood tests and treated with medication and lifestyle changes.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

The document concludes that more research is needed to confirm if blood tests for things like iron and vitamin D are helpful for hair loss from Telogen effluvium.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

The article suggests that five common skin-related lab tests may be unnecessary and could cause extra cost and anxiety without improving patient care.

Routine thyroid tests for diffuse alopecia in women may not be necessary, but checking for iron deficiency anemia could be useful.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Red ginseng may improve immunity, fatigue, memory, blood circulation, and menopausal symptoms, and is generally safe to consume.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.